KPJ to focus on Malaysia and exit other markets

Listed Malaysian hospital group KPJ Healthcare is selling non-core assets it holds outside of Malaysia to focus on its Malaysian hospital segment. It has already fully exited Indonesia and plans to fully exit Australia within the next two years, and may also exit Bangladesh. It still has a hospital in Thailand which it has no plans to sell, as it is focused on medical tourism - a key part of the company's strategy going forward. The company reported strong results for 2023, with revenue up 19% and core net profit up 61%.

Goldman Sachs raises $650m for life sciences

Global investment banking firm Goldman Sachs has closed one of the largest first-time private life sciences growth funds. Its West Street Life Sciences I raised "$650 million in equity commitments from a global, diverse group of institutional, strategic and high net worth investors and meaningful commitment from Goldman Sachs employees" according to the bank.

New weight loss drugs to create $100bn+ private health care market

New highly effective weight loss drugs could create a market worth more than $100bn in annual revenue by 2030. Whilst the majority of this value will be captured by the pharma industry, HBI hears there will be a significant role for specialised clinical providers who can deliver these medicines alongside behavioural and lifestyle changes. 

Cerba to enter Saudi Arabia

Multinational French labs group Cerba is to enter the Saudi market, via a joint venture with Nexus Gulf Healthcare (an investment firm in the region) that will be headquartered in Riyadh.

Circle Health set to be sold for $1.2bn

PureHealth, an Abu Dhabi group which is effectively state-owned, is set to buy Circle Health, the UK's second largest hospital group by revenue, for $1.2bn. The deal follows PureHealth's acquisition of a minority stake in a major US hospital chain. It comes as revenue from both private pay and NHS outsourcing surges in the UK.

Opportunities in diagnostic imaging and teleradiology

The imaging sector presents a significant opportunity for private investors and operators, given its strong fundamentals and low levels of consolidation. Speakers on the ‘Opportunities in diagnostic imaging and teleradiology’ panel at HBI 2023 were particularly enthusiastic about the opportunity in Germany and France, and about building teleradiology platforms.

Interview: Simon Miller, Headspace

HBI speaks to Simon Miller, Headspace’s international partner lead, about the company’s long-term vision to create a digital mental health platform offering a personalised service across a wide continuum of care. 

Find Us